3D Medicines, Inc. (HK:1244) has released an update.
3D Medicines Inc. has successfully passed all proposed resolutions during their Annual General Meeting on June 28, 2024, with overwhelming shareholder support. Key approvals included the adoption of audited financial statements, re-election of directors, and appointment of a new company auditor. Shareholders also granted the board mandates to issue additional shares and repurchase shares, enhancing the company’s financial flexibility.
For further insights into HK:1244 stock, check out TipRanks’ Stock Analysis page.
